Article
Lower PSA threshold may improve test's clinical value
Author(s):
Seattle-A new study suggests that a lower PSA threshold for consideringa prostate biopsy may improve the clinical value of the widely used test.In addition, lowering the threshold for biopsy may be particularly importantfor men under the age of 60 years, according to researchers from Brighamand Women's Hospital in Boston and Washington University School of Medicinein St. Louis.
Related Videos
Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
Alternative treatments and patient communication for genitourinary syndrome of menopause
Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
Prostate cancer screening: Expert weighs in after Biden's diagnosis
Sarah Razavi, MD, discusses the physical toll of ureteroscopy on urologists
Clinical Outcomes of Ultra-Low PSA Responses in Patients With mHSPC Receiving Darolutamide Plus ADT
Treatment or Lack of Treatment of Small Renal Masses
The current treatment landscape of mHSPC
Strengths and Weaknesses of Imaging Modalities in ccRCC
BPH: Strategies for Guiding Patients From Medication to Intervention
Related Content
